Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05794295 · ClinicalTrials.gov registry record · NA

Sleep Architecture & Cognition in Focal Epilepsy

A NA study of Focal Epilepsy, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05794295 is a NA study of Focal Epilepsy that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 40 participants, below the 167-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05794295, a NA study of Focal Epilepsy, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the overnight stays, participants will have EEG leads placed and possibly a headband. They will undergo cognitive testing before they go to sleep and again in the morning. During one night of testing, sounds will be played in the room (acoustic stimulation). The sounds should not wake the participants.

Conditions Studied

Interventions

  • OTHER Acoustic Stimulation (AS)
  • OTHER SHAM Stimulation

Study Locations (1)

California

  • UC Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-24
Est. Completion 2028-06
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT05794295

The ClinicalTrials.gov registry entry for NCT05794295 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (76% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Focal Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Acoustic Stimulation (AS) is the first listed.

NCT05794295 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05794295 about?

NCT05794295 is a clinical study titled "Sleep Architecture & Cognition in Focal Epilepsy". Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the overnigh...

What is the current status of trial NCT05794295?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-24. Estimated completion is 2028-06.

What conditions does trial NCT05794295 study?

This clinical trial studies the following conditions: Focal Epilepsy.

What interventions are being tested in trial NCT05794295?

The interventions under investigation include: Acoustic Stimulation (AS) (OTHER), SHAM Stimulation (OTHER).

Who is sponsoring clinical trial NCT05794295?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05794295 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Focal Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.